Patients with severe Coronavirus Disease 2019 (COVID-19) are treated with corticosteroids. We aimed to evaluate the role of corticosteroid treatment in candidemia development during the COVID-19 pandemic. This retrospective study was conducted in a Greek ICU, from 2010 to August 2021, encompassing a pre-pandemic and a pandemic period (pandemic period: April 2020 to August 2021). All adult patients with candidemia were included. During the study period, 3,572 patients were admitted to the ICU, 339 patients during the pandemic period, of whom 196 were SARS-CoV-2-positive. In total, 281 candidemia episodes were observed in 239 patients, 114 in the pandemic period. The majority of candidemias in both periods were catheter-related (161; 50.4%). The incidence of candidemia in the pre-pandemic period was 5.2 episodes per 100 admissions, while in the pandemic period was 33.6 (p < 0.001). In the pandemic period, the incidence among COVID-19 patients was 38.8 episodes per 100 admissions, while in patients without COVID-19 incidence was 26.6 (p = 0.019). Corticosteroid administration in both periods was not associated with increased candidemia incidence. A significant increase of candidemia incidence was observed during the pandemic period in patients with and without COVID-19. This increase cannot be solely attributed to immunosuppression (corticosteroids, tocilizumab) of severe COVID-19 patients, but also to increased workload of medical and nursing staff.

Introduction: Candida auris (now Candidozyma auris) and multidrug-resistant (MDR) bacterial infections pose significant therapeutic challenges due to high antimicrobial resistance, increased mortality, and persistence in healthcare settings. In Greece, their rising prevalence is raising concerns regarding co-infection, yet comprehensive data remain limited. This study aims to investigate the epidemiology, risk factors, and clinical outcomes of MDR bacterial co-infection in patients with C. auris candidemia. Methods: This single-center, retrospective observational cohort study was conducted at a Greek tertiary university hospital and included adult patients with C. auris bloodstream infections from January 2019 to June 2024. The data were analyzed using appropriate statistical methodologies. Results: Among 96 patients, those with C. auris candidemia and MDR bacterial co-infection exhibited a significantly higher mortality rate (87.23% vs. 61.22%, p = 0.007). The presence of a central venous catheter was the only factor significantly associated with MDR co-infection (p = 0.030). In univariate analysis, MDR co-infection, a higher Charlson Comorbidity Index, and mechanical ventilation correlated with increased mortality. Multivariate analysis identified MDR co-infection (OR = 3.19, p = 0.045) and mechanical ventilation (OR = 7.07, p = 0.002) as independent mortality predictors. Conclusions: These findings underscore the need for enhanced surveillance, precise identification, and stringent infection control measures to prevent C. auris and MDR bacterial outbreaks in healthcare settings.

Neisseria meningitidis is a major cause of invasive bacterial disease in infancy, usually presenting as meningitis and/or septicemia. Initial isolation of this organism from urine is exceptionally rare, particularly in young infants. We report a 74-day-old previously healthy infant who presented with fever without an apparent source. Urine obtained by sterile suprapubic aspiration unexpectedly grew N. meningitidis serogroup B. Blood culture subsequently confirmed invasive meningococcal disease, whereas cerebrospinal fluid (CSF) culture and multiplex PCR were negative despite pathologic CSF findings. The urinary isolate was therefore interpreted as probable secondary hematogenous seeding rather than primary urinary tract infection. The patient received ceftriaxone, with temporary escalation to meropenem because of persistent fever; neuroimaging excluded intracranial complications. Complement screening (50% hemolytic complement, CH50) was normal, and the infant recovered fully. This case illustrates an unusual microbiological presentation of probable invasive meningococcal disease, and highlights the importance of promptly interpreting unexpected culture results in febrile young infants.